In which situations do you offer ovarian suppression with chemotherapy to prevent the development of premature menopause in premenopausal women with ER negative breast cancer?

Topics: Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Fertility Preservation • University of Iowa • NCI-CCC Breast Tumor Board Question • Breast Cancer, Non-metastatic

Fertility preservation already complete with embryo cryopreservation

Answer from: Medical Oncologist at Community Practice

I would consider the use of GnRHa during chemotherapy in all women that are premenopausal at breast cancer diagnosis (irrespective of age) and that are concerned about developing the side effects of early menopause. Current evidence supports its use as a standard strategy for ovarian function preser...

Related Questions